查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375862

综合代谢组测试市场规模、份额、趋势分析报告：按分析项目、疾病、最终用途、地区和细分市场进行预测，2023-2030 年

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

综合代谢组测试市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球综合代谢组测试市场规模预计将达到 208.7 亿美元。

预计2023年至2030年该市场将以9.1%的年复合成长率扩张。全球疾病负担的增加和新诊断产品的出现推动了市场

慢性病盛行率的上升以及遏制医疗保健支出的需求日益增长，预计将增加对疾病早期诊断和定期监测的需求，从而推动 CMP 检测市场的发展。生物晶片、微阵列和伴随诊断等技术先进产品的推出正在推动对早期异常检测的需求。 CMP 测试提供了一种经济有效且节省时间的方法来评估 14 种分析物，以识别、诊断和监测多种疾病。

消费者对医疗保健的认识不断提高是预计推动 CMP 测试市场的关键因素之一。世界各地的许多组织正在努力提高人们对这种疾病、可用治疗方案以及早期诊断和预防措施的好处的认识。例如，国际糖尿病基金会和美国糖尿病协会透过多次宣传活动和其他广告方式，带头强调糖尿病诊断和监测的迫切需求。它们是一个团体的一部分。

在综合代谢组测试市场中，由于产品价格有细微差异，消费者购买行为较为复杂。不同市场参与者提供的产品进行策略性定价，以增加竞争公司之间的对抗关係。随着市场竞争变得更加激烈，消费者对改善诊断的需求，包括安全性、有效性、敏感性和特异性，预计将达到历史最高水准。

近年来，随着改进的诊断产品的推出和生物标记的引入，医疗诊断领域经历了范式转移。然而，復发和疾病进展仍然很高，特别是在老年人中。强烈的未满足需求代表了在 CMP 测试领域开发创新的一流诊断技术的重要机会。

综合代谢面板测试市场报告亮点

  • 肾臟疾病细分市场在 2022 年占据最大销售份额，达到 32.71%，该细分市场受到高疾病盛行率和分析物最大利用率的推动。
  • 预计糖尿病领域在预测期内将以 9.9% 的年复合成长率增长最快。近 50% 的糖尿病患者仍未被诊断，这为综合代谢检测市场创造了利润丰厚的成长机会。
  • PoC 领域预计在预测期内将以 9.8% 的最快年复合成长率成长。 PoC CMP 测试的驱动力是易于操作、便携、快速获得结果和低样品要求。
  • 由于易于取得、市场渗透率高、使用量不断增加以及具有临床意义的结果，实验室细分市场在 2022 年占据了最高的销售份额，达到 59.97%。
  • 受医疗基础设施改善、更容易患慢性病的老年人数量增加、消费者意识增强、可支配所得增加以及整体经济发展的推动，亚太地区在预测期内将以 11.7% 的年复合成长率增长。具有最高的增长。

目录

第1章调查方法和范围

第2章执行摘要

第3章综合代谢组测试市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 综合代谢面板测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章综合代谢组测试市场：分析估计/趋势分析

  • 综合代谢组测试市场：重点
  • 综合代谢组测试市场：2022 年和 2030 年趋势和市场占有率分析
  • K+
  • 钠+
  • Cl-
  • CO2
  • 葡萄糖
  • 货车
  • 肌酸酐
  • Ca++
  • 白蛋白
  • 总蛋白
  • ALP
  • 选择
  • AST
  • 总胆红素

第5章综合代谢组检测市场：疾病估计与趋势分析

  • 综合代谢组测试市场：重点
  • 综合代谢组测试市场：2022 年和 2030 年趋势和市场占有率分析
  • 肾臟疾病
  • 肝病
  • 糖尿病
  • 其他的

第6章综合代谢组测试市场：最终用途估计与趋势分析

  • 综合代谢组测试市场：重点
  • 综合代谢组测试市场：2022 年和 2030 年趋势和市场占有率分析
  • 实验室
  • 示范实验
  • 概念验证（设备）

第7章综合代谢组检测市场：区域估算与趋势分析

  • 区域展望
  • 按地区分類的综合代谢面板测试市场：主要市场点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings
    • Sonic Healthcare Limited
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Biomedical
Product Code: GVR-3-68038-747-6

Comprehensive Metabolic Panel Testing Market Growth & Trends:

The global comprehensive metabolic panel testing market size is expected to reach USD 20.87 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 9.1% from 2023 to 2030. The market driven by an increasing global disease burden and the emergence of novel diagnostic products.

Rising prevalence of chronic diseases coupled with increasing need to curb healthcare expenditure are expected to boost the CMP testing market by increasing the demand for early disease diagnosis and regular monitoring. Introduction of technologically advanced products, such as biochips, microarrays, and companion diagnostics, has driven the necessity for early detection of anomalies. CMP testing offers a cost-effective and time-saving method for evaluating 14 analytes for identification, diagnosis, or monitoring of several diseases.

Rising consumer awareness regarding healthcare is one of the major factors anticipated to drive the market for CMP testing. Many organizations worldwide are working toward increasing awareness pertaining to diseases, available treatment options, and benefits of early diagnosis and precautions. For instance, the International Diabetes Foundation and the American Diabetes Association are some of the key organizations that emphasize the urgent need for diagnosing and monitoring diabetes through several awareness campaigns and other modes of advertisement.

The buying behavior of consumers is moderately complex in the comprehensive metabolic panel testing market, due to subtle differences in product prices. The products offered by various market players have been strategically priced to increase competitive rivalry. As the market becomes increasingly competitive, consumer needs are anticipated to reach at an all-time high for improved diagnostics - in terms of safety, efficacy, sensitivity, and specificity.

The medical diagnostics landscape has undergone a paradigm shift over the last few years, driven by the launch of improved diagnostic products and introduction of biomarkers. However, recurrence and disease progression remain high, especially among geriatric patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnostics in the CMP testing space.

Comprehensive Metabolic Panel Testing Market Report Highlights:

  • The kidney diseases segment accounted for the largest revenue share of 32.71% in 2022, and the segment is driven by a high disease prevalence and maximum utilization of analytes.
  • The diabetes segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. Nearly 50% of diabetics remain undiagnosed, presenting a lucrative opportunity for growth for the comprehensive metabolic panel testing market.
  • The PoC segment is expected to grow at the fastest CAGR of 9.8% over the forecast period. The PoC CMP tests are driven by their ease of operation, portability, speed of results, and lesser requirement of the sample.
  • The laboratories segment accounted for the highest revenue share of 59.97% in 2022, driven by easy availability, high market penetration, increased usage, and clinically significant results.
  • Asia Pacific is expected to grow at the highest CAGR of 11.7% over the forecast period, driven by improvements in healthcare infrastructure, a rise in the number of older people, who are more susceptible to chronic illnesses, growth in consumer awareness, a rise in disposable income, and overall economic development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Analytes
    • 1.1.2. Disease
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Analytes outlook
    • 2.2.2. Disease outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Comprehensive Metabolic Panel Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Comprehensive Metabolic Panel Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Comprehensive Metabolic Panel Testing Market: Analytes Estimates & Trend Analysis

  • 4.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 4.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. K+
    • 4.3.1. K+ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Na+
    • 4.4.1. Na+ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cl-
    • 4.5.1. Cl- market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. CO2
    • 4.6.1. CO2 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Glucose
    • 4.7.1. Glucose market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. BUN
    • 4.8.1. BUN market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Creatinine
    • 4.9.1. Creatinine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Ca++
    • 4.10.1. Ca++ market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Albumin
    • 4.11.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Total Protein
    • 4.12.1. Total protein market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. ALP
    • 4.13.1. ALP market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. ALT
    • 4.14.1. ALT market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. AST
    • 4.15.1. AST market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. Total Bilirubin
    • 4.16.1. Total bilirubin market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Comprehensive Metabolic Panel Testing Market: Disease Estimates & Trend Analysis

  • 5.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 5.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Kidney Diseases
    • 5.3.1. Kidney diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Liver Diseases
    • 5.4.1. Liver diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Comprehensive Metabolic Panel Testing Market: End-Use Estimates & Trend Analysis

  • 6.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
  • 6.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Laboratories
    • 6.3.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. Emergency departments
      • 6.3.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.3. Hospital wards
      • 6.3.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.4. Primary care
      • 6.3.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.5. Pharmacy
      • 6.3.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.6. Telemedicine
      • 6.3.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. PoC
    • 6.4.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Emergency departments
      • 6.4.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Hospital wards
      • 6.4.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Primary care
      • 6.4.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Pharmacy
      • 6.4.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Telemedicine
      • 6.4.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. PoC (Instruments)
    • 6.5.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Piccolo Xpress
      • 6.5.2.1. Piccolo xpress market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. Skyla-HB1
      • 6.5.3.1. Skyla-HB1 market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. DRI-CHEM NX500
      • 6.5.4.1. DRI-CHEM NX500 market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Comprehensive Metabolic Panel Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Quest Diagnostics
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Laboratory Corporation of America Holdings
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Sonic Healthcare Limited
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Unipath
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. SYNLAB International GmbH
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. ARUP Laboratories
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Genoptix Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Nova Biomedical
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 3 North America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 4 North America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 7 U.S. comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 8 U.S. comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 10 Canada comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 11 Canada comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 13 Europe comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 14 Europe comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 17 Germany comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Germany comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 20 UK comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 21 UK comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 23 France comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 24 France comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 26 Italy comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 27 Italy comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 29 Spain comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 30 Spain comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 32 Denmark comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 33 Denmark comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 35 Sweden comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 36 Sweden comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 38 Norway comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 39 Norway comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 45 Japan comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 46 Japan comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 48 China comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 49 China comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 51 India comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 52 India comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 54 Australia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 55 Australia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 57 Thailand comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 58 Thailand comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 60 South Korea comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 61 South Korea comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 63 Latin America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 64 Latin America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 67 Brazil comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 68 Brazil comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 70 Mexico comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 71 Mexico comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 73 Argentina comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 74 Argentina comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 80 South Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 81 South Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 86 UAE comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 87 UAE comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
  • Table 89 Kuwait comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
  • Table 90 Kuwait comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Comprehensive metabolic panel testing: Market outlook
  • Fig. 8 Comprehensive metabolic panel testing: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Comprehensive metabolic panel testing market driver impact
  • Fig. 13 Comprehensive metabolic panel testing market restraint impact
  • Fig. 14 Comprehensive metabolic panel testing market strategic initiatives analysis
  • Fig. 15 Comprehensive metabolic panel testing market: Disease movement analysis
  • Fig. 16 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
  • Fig. 17 Kidney diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Liver diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Comprehensive metabolic panel testing market: Disease movement analysis
  • Fig. 22 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
  • Fig. 23 K+ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Na+ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cl- market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 CO2 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Glucose market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 BUN market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Creatinine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Ca++ market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Total protein market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 ALP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 ALT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 AST market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Total bilirubin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Comprehensive metabolic panel testing market: End-Use movement analysis
  • Fig. 38 Comprehensive metabolic panel testing market: End-Use outlook and key takeaways
  • Fig. 39 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 PoC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 PoC (instruments) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Global comprehensive metabolic panel testing market: Regional movement analysis
  • Fig. 43 Global comprehensive metabolic panel testing market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)